Abstract:Haibin Shi, 1 Minmin Chen, 2 Caihong Zheng, 2 Bian Yinglin, 2 Bin Zhu 2 1 Department of Anesthesiology, the Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China; 2 Department of Anesthesiology, Hangzhou Women's Hospital, Hangzhou, Zhejiang, People's Republic of China Correspondence: Bin Zhu, Department of Anesthesiology, Hangzhou Women's Hospital, 369 Kunpeng, Shangcheng District, Hangzhou City, Zhejiang Province, 310000, People's Republic of China, Tel +86 13758136317, Email Purpose: Paclitaxel-induced peripheral neuropathy (PIPN) constitutes a refractory and progressive adverse consequence of paclitaxel treatment, causing pain and sensory anomalies in cancer survivors. Although the gut-brain axis is involved in multiple disorders including cancer, its impact on peripheral pain conditions remains elusive. Thus, we assessed the importance of gut microbiota and related mechanisms in PIPN. Methods: By implementing fecal microbiota transplantation (FMT) in a rat PIPN model (ie, rats treated with paclitaxel; hereafter as PIPN rats), we explored the effect of gut microbiota on PIPN rats using multiple methods, including different behavioral tests, 16S ribosomal DNA (rDNA) sequencing, and biochemical techniques. Results: Sequencing of 16S rDNA revealed that the abundance of genera Bacteroides and UCG-005 increased, while that of genera Turicibacter, Clostridium sensu stricto 1 and Corynebacterium decreased in the PIPN rats. However, when treated with FMT using fecal from normal rats, the mechanical allodynia and thermal hyperalgesia in PIPN rats were significantly alleviated. In addition, FMT treatment reduced the expression of toll-like receptor 4 (TLR4), phospho-p38 mitogen-activated protein kinase (p-p38MAPK), and the astrocytic marker glial fibrillary acidic protein in the colon and spinal dorsal horn. TAK242 (a TLR4 inhibitor) significantly alleviated the behavioral hypersensitivity of PIPN rats and inhibited the TLR4/p38MAPK pathway in astrocytes in these rats. Conclusion: The gut microbiota played a critical role in PIPN. Future therapies treating PIPN should consider microbe-based treatment as an option. Keywords: astrocyte, gut microbiota, paclitaxel, p38, peripheral neuropathy, TLR4 Chemotherapeutic drugs, such as paclitaxel, are widely used in treating patients with tumors, 1 such as breast cancer, 2,3 ovarian cancer, 4,5 and lung cancer. 6 However, these drugs can cause adverse consequences, including chemotherapy-induced peripheral neuropathy (specifically, for paclitaxel, it is known as paclitaxel-induced peripheral neuropathy (PIPN)). PIPN occurs in about 97% of patients receiving paclitaxel treatment, significantly affecting these patients' quality of life. 7 The main symptoms include pain, numbness, paresthesia and hypersensitivity to mechanical or cold stimuli. 8 The underlying mechanisms regulating PIPN remain elusive, but inflammatory cytokines are presumably involved in the pathogeny of this adverse event. 9 Nowadays, PIPN remains a challenge for patients receiving chemotherapy. Toll-like receptor 4 (TLR4) regulates pain chronification. 10,11 The activity of TLR4 combined with mitogen-activated protein kinases (MAPKs) has been previously documented in PIPN. 12 During the initiation and progression of PIPN, TLR4 was activated in the astrocytes of the spinal cord. 13 This activation further triggers the release of interleukin-1β (IL-1β) and tumor necrosis factor-alpha (TNF-α), among others, which can sensitize nociceptive neurons and trigger neurogenic inflammation. 14 Similarly, the activation of astrocytes can contribute to neuroinflammation and central sensitization in PIPN. 15–17 Thus, the pathophysiology of PIPN likely involves astrocytes, TLR4, and downstream MAPKs. Gut microbiota represents the diversified microorganisms residing within an individual's gastrointestinal tract. 18,19 The gut-brain axis defines a bidirectional cross-talk between the gut bacterial community and brain through a network of signaling systems involved in host physiology, 20 metabolism 21,22 and neurodegenerative disorders. 23,24 An interruption in the balance of the microbiota can lead to dysbiosis, affecting the onset and progression of several pathologies, eg, inflammatory bowel disease, 25 irritable bowel syndrome, 26 neuropsychiatric disorders, 27,28 and other pain conditions. 29,30 A large number of PIPN events linked with gut microbiota dysbi -Abstract Truncated-

Is Aspartame Really Safer in Reducing the Risk of Hypoglycemia During Exercise in Patients With Type 2 Diabetes?

Administration of a Probiotic Mixture Ameliorates Cisplatin-Induced Mucositis and Pica by Regulating 5-HT in Rats

The role of the gut microbiome in neuroinflammation and chemotherapy-induced peripheral neuropathy

Neuroimaging uncovers neuronal and metabolic changes in pain modulatory brain areas in a rat model of chemotherapy-induced neuropathy – MEMRI and ex vivo spectroscopy studies

The Endocannabinoid System of the Nervous and Gastrointestinal Systems Changes after a Subnoxious Cisplatin Dose in Male Rats

Monoclonal Antibody Targeting CGRP Relieves Cisplatin-Induced Neuropathic Pain by Attenuating Neuroinflammation

The Gut Microbial Lipid Metabolite 14(15)-EpETE Inhibits Substance P Release by Targeting GCG/PKA Signaling to Relieve Cisplatin-Induced Nausea and Vomiting in Rats

Meclizine and Metabotropic Glutamate Receptor Agonists Attenuate Severe Pain and Ca2+ Activity of Primary Sensory Neurons in Chemotherapy-Induced Peripheral Neuropathy

Prebiotics counteract the morphological and functional changes secondary to chronic cisplatin exposition in the proximal colon of mice

Berberine Alleviate Cisplatin-Induced Peripheral Neuropathy by Modulating Inflammation Signal via TRPV1

Gut microbiota accelerates cisplatin-induced acute liver injury associated with robust inflammation and oxidative stress in mice

Fecal Microbiota Transplantation Alleviated Paclitaxel-Induced Peripheral Neuropathy by Interfering with Astrocytes and TLR4/p38MAPK Pathway in Rats

Transcriptome Profiling of miRNA-mRNA Interactions and Associated Mechanisms in Chemotherapy-Induced Neuropathic Pain

C-phycocyanin alleviated cisplatin-induced oxidative stress and inflammation via gut microbiota—metabolites axis in mice

Kinin B1 and B2 Receptors Contribute to Cisplatin-Induced Painful Peripheral Neuropathy in Male Mice

Gut microbiota is critical for the induction of chemotherapy-induced pain

Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain

Gut-derived metabolite 3-methylxanthine enhances cisplatin-induced apoptosis via dopamine receptor D1 in a mouse model of ovarian cancer

Connexin 43 mediated mitochondrial transfer prevents cisplatin induced sensory neurodegeneration.

Gut microbiota mediates the protective effects of β-hydroxybutyrate against cisplatin-induced acute kidney injury

Palladium-catalyzed oxidative carbocyclizations.